1355970-19-2

Upstream product

• 98-09-9 benzenesulfonyl chloride 
• 86762-06-3 4-chlorothieno[2,3-d]pyrimidine-6-carbonyl chloride 
• 86825-96-9 4-chlorothieno[2,3-d]pyrimidine-6-carboxylic acid 
• 367-21-5 3-chloro-4-fluorophenylamine 
• 1355969-44-6 (4-chlorothieno[2,3-d]pyrimidin-6-yl)(1-(phenylsulfonyl)-1H-indol-2-yl)methanone 
• 40899-71-6 1-benzenesulfonylindole 
• 120-72-9 indole 
• 14080-59-2 4-chlorothieno[2,3-d]pyrimidine 

Downstream Products

• 1355970-09-0 (4-(3-chloro-4-fluorophenylamino)thieno[2,3-d]pyrimidin-6-yl)(1H-indol-2-yl)methanone 
• 1355970-23-8 (4-((3-chloro-4-fluorophenyl)(methyl)amino)thieno[2,3-d]pyrimidin-6-yl)(1H-indol-2-yl)methanone 
• 1355970-21-6 (4-((3-chloro-4-fluorophenyl)(methyl)amino)thieno[2,3-d]pyrimidin-6-yl)(1-(phenylsulfonyl)-1H-indol-2-yl)methanone 

Relevant academic research and scientific papers

Novel inhibitors of epidermal growth factor receptor: (4-(Arylamino)-7H- pyrrolo[2,3-d]pyrimidin-6-yl)(1H-indol-2-yl)methanones and (1H-indol-2-yl)(4- (phenylamino)thieno[2,3-d]pyrimidin-6-yl)methanones

Several members of the quinazoline class of known tyrosine kinase inhibitors are approved anticancer agents, often showing selectivity for receptors of the HER/ErbB-family. Combining structural elements of this class with the bisindolylmethanone-structure